Ovarian low malignant potential tumors have abnormal cells that may become cancer, but usually do not. Role of hysterectomy and lymphadenectomy in the management of. A novel multiple marker bioassay utilizing he4 and ca125 for the prediction of ovarian cancer in patients with a pelvic mass. Borderline tumors exhibit epithelial proliferation and cytologic atypia, beyond that acceptable for a benign neoplasm, but do not exhibit the destructive growth seen in carcinomas. Microinvasion links ovarian serous borderline tumor and. In addition, approximately 20%30% of ovarian tumors diagnosed as borderline ovarian tumors at the time of frozen section examination prove to be carcinomas on further samplingmore so for mucinous tumors than serous tumors 33% vs. This report was developed from discussions at the workshop. It has been suggested that this finding may support the concept that borderline tumours represent a disease that is distinct from invasive ovarian cancer. Ovarian serous borderline tumor sbt and grade 1 low grade serous carcinoma are closely related, but, unlike sbt which has been well studied, there have been few studies looking primarily at grade 1 serous carcinoma. Pdf borderline ovarian tumors represent a heterogeneous group of noninvasive tumors of uncertain malignant potential with characteristic histology find. The objective of this study was to better understand the relationship between serous borderline tumors and grade 1 serous. Intestinaltype mucinous borderline ovarian tumors imbots and welldifferentiated mucinous carcinomas manifest at stage i in most cases.
In stage i disease, no therapy in addition to surgery is needed, and conservation of ovarian tissue for future childbearing may be appropriate. They are also called tumors with low malignant potential. Nearly 75% of these tumors are stage i at the time of diagnosis. In 1898, hermann johannes pfannenstiel illustrated and described papillary ovarian. We aim to explore histologyspecific familial associations among bots and associations between bot and any invasive cancers. Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment. The mainstay of the management for borderline ovarian tumors remains surgery with removal of affected organs and anatomical sites 3 x 3 matsuo, k. Bot are rare gynecologic tumors and represent around 10% to 15% of epithelial ovarian tumors. Borderline ovarian tumours differ from epithelial ovarian cancer by their low incidence, frequent association with infertility, low association with mutations in bcra genes, different percentages of the most common histological types, early stage diagnosis, and high survival rate, even when associated with peritoneal involvement. Ovarian cancer is a relatively uncommon type of cancer that arises from different types of cells within the ovary, an almondshaped eggproducing female reproductive organ the most common ovarian cancers are known as epithelial ovarian cancers eoc or ovarian carcinoma other types of ovarian cancer include ovarian low malignant potential tumor olmpt, germ cell tumors, and sex cord. Management of borderline ovarian tumors sciencedirect.
They represent about 65% of cases of borderline ovarian tumors. Please note that the guidelines listed are acrobat pdf. Apr 01, 2011 of the 35 patients who had a recurrence, 2 were diagnosed clinically, both are alive with progressive disease at 1 and 5 years after the diagnosis of the recurrence. Trends in incidence of borderline ovarian tumors in. Ovarian tumors are a heterogeneous group of tumors including surface epithelial tumors, germ cell tumors, and sex cord stromal tumors. They tend to grow slowly and more controlled than cancer cells. Management of borderline ovarian tumors annals of oncology. May 10, 2018 borderline ovarian tumors are a type of epithelial ovarian tumors that exhibit some characteristics of malignancy, but appear to still be early enough in their development to be treated successfully. Bot patients have a good prognosis with 5 and 10year survival rates of 95 and 92. With tumors of this kind, the usual course of treatment is to surgically remove the growth and conduct a biopsy. Borderline ovarian tumors bot are defined by figo committee as low malignant potential tumor. Maria guadalupe patrono 1, lucas minig 1, ivan diazpadilla 2, nuria romero 2, juan francisco rodriguez moreno 2 and jesus garciadonas 2. Since then, it has been recognized that the two categories are heterogonous.
Borderline ovarian tumors bot are epithelial tumors of the ovaries with both malignant and nonmalignant aspects. This tumor often is associated with a significantly better prognosis than epithelial ovarian cancer. Mar 11, 2020 to investigate the value of ct and mr imaging features in differentiating borderline ovarian tumor bot from type i ovarian epithelial cancer oec, which could be significant for suitable clinical treatment and assessment of the prognosis of the patient. When disease is found in one ovary, the other ovary should also be checked carefully for signs of disease. Controversies in borderline ovarian tumors received may 6, 2015 revised jul 16, 2015 accepted aug 31, 2015. Doctors cant be sure whether a tumor is invasive or borderline until a biopsy sample has been taken usually. Borderline ovarian tumors bots differ from the epithelial ovarian malignancies with their excellent prognosis, curabili ty with surgery, and being seen in. Data were obtained from hospital records and special gynecologic oncology forms. Borderline epithelial tumors of the ovary modern pathology. The objective of this study was to identify clinicopathological factors that impact prognosis of patients with borderline ovarian tumors bot and to address features of. In advanced stages, the use of adjuvant therapy has not consistently led to. Pdf borderline ovarian tumors milica zivaljevic and. Serous borderline ovarian tumors are the most common.
Epithelial tumours, which account for about 75% of all ovarian tumours, and 9095% of ovarian malignancies sex cordstromal tumours, which account for about 510 % of all ovarian neoplasms germ cell tumours, which account for about 1520 % of all ovarian neoplasms. All pathological features related to borderline tumors. Borderline tumors usually aff ect women between 20 and 40 years old. Ovarian low malignant potential tumor is a disease in which abnormal cells form in the tissue covering the ovary. Approximately, 3,000 cases of borderline ovarian tumors are annually diagnosed in the united states 7. This practice bulletin focuses on the primary genetic mutations associated with hereditary breast and ovarian cancer syndrome, brca1 and brca2, but also will briefly discuss some of the other genes that have been implicated. Borderline tumors 38 patients with ovarian borderline tumors treated conservatively. Management of borderline ovarian tumors pdf paperity.
Borderline tumors are considered to be precursors of lowgrade ovarian cancers. Borderline epithelial tumors low malignant potential lcoh6 malignant sex cordstromal tumors lcoh9. Borderline ovarian tumors account for approximately 15% of all epithelial ovarian tumors. Compared to invasive epithelial ovarian cancers, bot occurs more commonly at a younger age, during the time of optimum fertility. Fertility and prognosis of borderline ovarian tumor after. Epithelial ovarian cancers n129 22 borderline tumors 6 nonepithelial ovarian cancers 22 non ovarian cancers sensitivity specificity postmenopausal 92. Differentiation of borderline tumors from type i ovarian.
The concept of borderline epithelial tumors of the ovary has faced controversy for over a century. Borderline epithelial ovarian cancer low malignant potential less common ovarian histologies. Assessing the landscape of ovarian serous borderline tumors. Hereditary risk evaluation for borderline ovarian tumors. For a small number of higher risk borderline ovarian tumours follow up will include.
Tumor of borderline malignancy borderline tumor bt. The world health organization histological classification for ovarian tumors separates ovarian neoplasms according to the most probable tissue of origin. Identification of factors that impact recurrence in patients. This report describes a case of a typical serous borderline tumor of the ovary in a 6yearold pointer dog. Ms1 the discussion section has been updated to reflect the changes in the algorithm. Recurrence and prognostic factors in borderline ovarian tumors.
Pdf ovarian borderline tumors in the 2014 who classification. Borderline ovarian tumors bots comprise about 15% 20% of all epithelial ovarian malignancies, with an incidence of 1. Borderline epithelial tumors are also known as atypical proliferating tumors and used to be called low malignant potential tumors. About 15 out of every 100 15% ovarian tumors are borderline tumors. Borderline ovarian tumors bot account for 1520% of all ovarian tumors. Tumors of this type are not malignant and are usually treated by surgery. Methods our study group comprised 203 cases of serous borderline tumors subclassified as atypical proliferative serous tumors or as noninvasive lowgrade serous carcinomas. Patients with borderline ovarian tumors are, in general, 10. Prognosis is good with a global 95% 5year overall survival and 90% 10year overall survival 3,4. Borderline ovarian tumor stage 3 ovarian cancer inspire. Bots are typically detected 20 years earlier than invasive ovarian carcinoma. Im healing okay, got my staples out yesterday, where they told me my diagnosis. Research paper diagnostic accuracy of frozen section analysis. If you have any further questions or concerns, please do not hesitate to contact a doctor or nurse caring for you.
Ovarian low malignant potential tumors treatment pdq. Serous and mucinous borderline low malignant potential. The esmoesgo consensus conference manuscript on ovarian cancer was developed by a multidisciplinary panel of 40 leading experts and presents evidencebased recommendations in several areas in an effort to improve the quality of care for women with ovarian cancer. Keywords fertilitysparing surgery invasive implants laparoscopy salpingooophorectomy surgical staging tumour markers. Borderline ovarian tumors bots are a subgroup of ovarian malignancies with low malignant potential. Aim to compare distinct clinicopathological features between atypical proliferative serous tumors and noninvasive lowgrade ovarian serous carcinomas. The main histological criterion to differentiate it from malignancy is the absence of stromal invasion, but unlike benign forms, it has an increased mitotic index and the presence of nuclear atypia. The majority present at an early stage, but their diagnosis is often only made following surgery, hence the heterogeneity of surgical management. In advanced stages, the use of adjuvant therapy has not consistently led to cures, and complications have been reported. The national cancer institute sponsored a borderline ovarian tumor workshop held in august 2003 in bethesda, md. For most borderline ovarian tumours no routine follow up is required. Borderline ovarian tumors comprise a unique group of noninvasive ovarian neoplasms with characteristic histology and variable tumor biology that typically manifest as lowstage disease in younger women with resultant excellent prognosis. Borderline ovarian tumors are an intermediate stage between benign cystadenomas and adenocarcinomas. Unlike the invasive carcinomas, borderline ovarian tumors are characterized by cytoplasmic and nuclear atypia, element of differential diagnosis with benign.
Jnccn journal of the national comprehensive cancer network. Borderline tumors of the ovary also called tumors of lowmalignant potential are a heterogeneous group of lesions defined histologically by atypical epithelial proliferation without stromal invasion. There are two main types of borderline ovarian tumors. Pathology and classification of ovarian tumors chen 2003. Mar 16, 2020 webpathology is a free educational resource with 10308 high quality pathology images of benign and malignant neoplasms and related entities. Borderline mucinous tumors most frequently occur between the fourth and sixth decades of life. Borderline ovarian tumors have an excellent prognosis. Borderline ovarian tumours this leaflet will tell you what a borderline ovarian tumour is, what treatment you will receive, and what to expect after your treatment. Borderline ovarian tumorstumours of low malignant potential. Identification of factors that impact recurrence in. Ovarian cancer is the eighth most common malignancy in women worldwide with a mortality rate of over 140,000 deaths per year. The borderline ovarian tumor bot is an intermediate form between a benign and a malignant tumor. Origins and molecular pathology of ovarian cancer modern.
Management of borderline ovarian tumours obstetrics and. Nccn clinical practice guidelines in oncology nccn. Borderline ovarian tumors bot are epithelial tumors of the ovaries with both malignant and nonmalig nant aspects. Borderline ovarian tumor definition of borderline ovarian. On the one hand, they are characterized by cellular proliferation and nuclear atypia but, on the other hand, they usually do not show infiltrative growth pattern. These tumors look the same as invasive epithelial ovarian cancers when seen on an ultrasound or ct scan. Borderline ovarian tumors are a type of epithelial ovarian tumors that exhibit some characteristics of malignancy, but appear to still be early enough in their development to be treated successfully. Borderline tumours of the ovary, current controversies. Recurrence of borderline ovarian tumors experimental oncology. Surgery for borderline ovarian tumour patient information sheet borderline ovarian tumour is a condition in which abnormal cells form in the tissue covering the ovary. Borderline ovarian tumors most commonly current update on borderline.
Ninetyfour patients with borderline ovarian tumors were retrospectively analyzed for clinical features, treatments, and survival characteristics. Whats new in the 2014 who tumours of the female genital. Pdf diagnosis, treatment, and followup of borderline ovarian. Borderline tumors tend to affect younger women than the typical ovarian cancers. Treatment of ovarian low malignant potential tumors depends on tumor size and stage whether it affects part of or the whole ovary, or has spread to other parts of the body and the womans plans for having children.
Malignant cancerous or borderline low malignant potential ovarian tumors can spread metastasize to other parts of the body and can be fatal. This will also be done at 6 monthly intervals for 3 years and annually years 4 and 5. Although ovarian tumors are rare in dogs, epithelial tumors are the most frequently. Sep 28, 2012 in addition, approximately 20%30% of ovarian tumors diagnosed as borderline ovarian tumors at the time of frozen section examination prove to be carcinomas on further samplingmore so for mucinous tumors than serous tumors 33% vs. Occasionally, some abnormal cells come off the tumor and settle elsewhere in. In contrast, borderline ovarian tumors bots are a subgroup of ovarian malignancies with low malignant potential. The participants acknowledged several areas of disagreement on basic. These tumors can be benign not cancer, borderline low malignant potential, or malignant cancer. Borderline ovarian tumors american journal of obstetrics. The majority of women with borderline ovarian tumors have the disease confined in the ovary resulting in good prognosis. Borderline tumors represent approximately 10% to 15% of all epithelial ovarian malignancies.
Background borderline ovarian tumors bot are epithelial tumors of the ovaries with both malignant and nonmalignant aspects. Thirtythree patients with bots and 35 patients with type i oecs proven by pathology were retrospectively evaluated. Learn about types of surgery and other treatment options for ovarian low malignant potential tumors. The lack of consensus around best practices for management of borderline ovarian tumors bot is, in part, to the lack of available data and of clarity in interpreting relationships among various factors that impact outcomes. Epithelial ovarian tumors epithelial ovarian tumors start in the outer surface of the ovaries. Approximately 15% of all epithelial ovarian neoplasms are borderline tumors and the majority 70% are stage i at diagnosis. Very limited earlier data are available on familial clustering of bots with other cancers.
Pdf borderline ovarian tumors bot are uncommon but not rare epithelial ovarian neoplasms, intermediate between benign and malignant categories. Borderline ovarian tumors the american journal of medicine. Histological features serous borderline ovarian tumours are the most common histological type 50% and are bilateral in 30% of cases figure 1. Surgery for borderline ovarian tumour patient information. Mucinous borderline ovarian tumor mbot accounts for about 30% to 50% of all bots and are less likely to be bilateral 7% 10. Pdf unilateral typical type serous borderline ovarian. Incomplete staging surgery as a major predictor of relapse of. Borderline tumors usually affect women between 20 and 40 years old. Jan 27, 2011 i was just diagnosed yesterday with a borderline ovarian tumor, stage 3. I was told that if we want to have kids, we need to do so right away, after i have healed from surgery. Jun 01, 2005 limited experience with endocervical mulleriantype mucinous borderline tumors shows a possible relation to sbots in clinicopathologic features and biologic behavior. There are considerable discrepancies in the reported incidence of ovarian tumors of borderline. Pathology outlines who classification of ovarian neoplasms.
Objectives since the recognition of borderline ovarian tumors bots in the 1970s, the management of this subset of epithelial ovarian tumors has presented a challenge to clinicians. In the early 1970s, borderline tumors were categorized as either serous or mucinous with overall survival rates of 7590%. The paper evaluates the management of borderline ovarian tumors bots in the patients admitted. Only occasionally is a bot diagnosis from a frozen section further. However, even advanced stage borderline ovarian tumours are treated successfully. Epidemiology and taxonomy borderline ovarian tumors are relatively uncommon with an incidence of 1. The behavior of these tumors is distinct from lowgrade ovarian carcinoma and they are considered a distinct clinical entity. Borderline ovarian tumors are different from cancer figure 1 because they do not grow in ovarian support tissue the stroma. Borderline ovarian tumors are morphologically diverse, and their. Ovarian tumours are subdivided into 5 main categories according to the world health organizations classification system. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Most tumors are either serous or mucinous in histology and. The patients treated for borderline ovarian tumors were evaluated retrospectively.
684 724 1206 475 706 205 722 1116 176 19 413 95 1093 1127 678 1435 521 213 1064 1017 62 959 489 353 255 589 490 919 89 511 91 281 165 392 1110 558 223 1070 1270 666 864 527